ATE417621T1 - Kräuterzusammensetzungen zur behandlung von schleimhautläsionen - Google Patents

Kräuterzusammensetzungen zur behandlung von schleimhautläsionen

Info

Publication number
ATE417621T1
ATE417621T1 AT02733198T AT02733198T ATE417621T1 AT E417621 T1 ATE417621 T1 AT E417621T1 AT 02733198 T AT02733198 T AT 02733198T AT 02733198 T AT02733198 T AT 02733198T AT E417621 T1 ATE417621 T1 AT E417621T1
Authority
AT
Austria
Prior art keywords
treatment
skin lesions
herbal compositions
compositions
mucous skin
Prior art date
Application number
AT02733198T
Other languages
English (en)
Inventor
William Levine
Aron Saffer
Mina Faran
Original Assignee
Herbal Synthesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbal Synthesis Corp filed Critical Herbal Synthesis Corp
Application granted granted Critical
Publication of ATE417621T1 publication Critical patent/ATE417621T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02733198T 2001-05-23 2002-05-22 Kräuterzusammensetzungen zur behandlung von schleimhautläsionen ATE417621T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL14331801A IL143318A0 (en) 2001-05-23 2001-05-23 Herbal compositions for the treatment of mucosal lesions

Publications (1)

Publication Number Publication Date
ATE417621T1 true ATE417621T1 (de) 2009-01-15

Family

ID=11075430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02733198T ATE417621T1 (de) 2001-05-23 2002-05-22 Kräuterzusammensetzungen zur behandlung von schleimhautläsionen

Country Status (10)

Country Link
US (5) US7563466B2 (de)
EP (1) EP1395271B1 (de)
JP (1) JP4465155B2 (de)
AT (1) ATE417621T1 (de)
CA (1) CA2447180C (de)
DE (1) DE60230407D1 (de)
ES (1) ES2319968T3 (de)
IL (1) IL143318A0 (de)
PT (1) PT1395271E (de)
WO (1) WO2002094300A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
IL153124A (en) 2002-11-27 2010-06-30 Herbal Synthesis Corp Solid composition that can be glued to the lining
EP1591125A1 (de) * 2004-04-19 2005-11-02 Universitätsklinikum Freiburg Pharmazeutische Zusammensetzung enthaltend Extrakte aus Flechten und Johanniskraut
BRPI0403688A (pt) * 2004-09-01 2006-05-02 Herbarium Lab Botan Ltda composto fitoterápico tópico para tratamento de herpes
CA2587565C (en) * 2004-11-22 2016-06-21 Izun Pharmaceuticals Corporation Transmucosal delivery device
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
JP5024505B2 (ja) * 2005-03-25 2012-09-12 ライオン株式会社 歯周病に起因する高脂血症改善剤、ならびに口腔用組成物及び内服薬
FR2884144B1 (fr) * 2005-04-07 2008-04-11 Eric Peltier Combinaison d'un fixateur histologique ou cytologique, et d'un ou plusieurs composes photoactivables de la famille des quinones, en particulier l'hypericine, l'hypocrelline a et l'hypocrelline b.
DE102005019653A1 (de) 2005-04-26 2006-11-02 Henkel Kgaa Pflanzenextrakte gegen Halitosis, Gingivitis oder Parodontitis
US20070071840A1 (en) * 2005-09-27 2007-03-29 Sridevi Dhanaraj Method for treatment of cartilage disorders with centella extract
US7491414B2 (en) * 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea
WO2007149902A1 (en) * 2006-06-20 2007-12-27 Izun Pharmaceuticals Corporation Anti-inflammatory dissolvable film
AU2013242845B2 (en) * 2006-06-20 2015-09-03 Izun Pharmaceuticals Corporation Anti-inflammatory dissolvable film
ES2605794T3 (es) 2006-07-20 2017-03-16 Izun Pharmaceuticals Corporation Película, parche o formulación sólida adhesiva que comprende Sambucus nigra, Centella asiatica y sal de 1-alquilpiridinio para el tratamiento de tejidos mucosos
EP1882473A1 (de) * 2006-07-28 2008-01-30 Indena S.P.A. Verwendung von Anthocyanosiden zur Herstellung von Formulierungen zur Behandlung der Mucositis die durch antitumorale Mittel verursacht wird
GB0625430D0 (en) * 2006-12-20 2007-01-31 Mars Uk Ltd Composition
KR101660246B1 (ko) * 2008-07-22 2016-09-27 이준 파마슈티컬스, 인코포레이티드 국소 항염증 조합물
US8709506B2 (en) 2010-01-11 2014-04-29 Vitro Bio Sarl Synergistic compositions for the treatment of topical viral infections
WO2011124493A1 (de) * 2010-03-29 2011-10-13 Reiner Rittinghausen Zusammensetzung enthaltend bestandteile aus sonnenhut, holunder und kamille zur behandlung von erkältungskrankheiten
IT1402018B1 (it) * 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
BR112014022694B1 (pt) * 2012-03-14 2021-03-09 Izun Pharmaceuticals Corp. método para a preparação de uma composição aquosa terapêutica, extrato de ervas e composição farmacêutica contendo o referido extrato
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
EP2792389B1 (de) * 2013-04-17 2019-09-18 Global Health Solutions AG Antivirale Pharmazeutische Zusammensetzung, enthaltend einen Extrakt von Juncus acutus.
EP3057601A4 (de) 2013-10-14 2017-06-21 Izun Pharmaceuticals Corp. Verfahren zur behandlung von m-tor-inhibitor-assoziierter stomatitis
JP6294773B2 (ja) * 2014-06-27 2018-03-14 株式会社ナールスコーポレーション 口腔粘膜疾患の予防または治療用経口製剤
RU2583885C1 (ru) * 2015-01-12 2016-05-10 Сергей Витальевич Аверьянов Мазь для лечения хейлитов
CN104758697A (zh) * 2015-04-20 2015-07-08 于风叶 治疗复发性口腔溃疡的中药散剂
BR112018071518A2 (pt) 2016-04-22 2019-02-19 Receptor Life Sciences, Inc. compostos medicinais à base de planta de ação rápida e suplementos nutricionais
ITUA20163253A1 (it) * 2016-05-09 2017-11-09 Giacomo Bruzzesi Uncaria tomentosa per uso odontoiatrico
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
CN108524625A (zh) * 2018-05-31 2018-09-14 广州聚澜健康产业研究院有限公司 一种补肾益阴胶囊及其制备方法
IT201800009621A1 (it) 2018-10-19 2020-04-19 Roberto Soldati Composizione fitoterapica ozonizzata per la rigenerazione tissutale e ossea
EP3883595A4 (de) 2018-11-19 2022-12-14 Receptor Holdings, Inc. N-acylierte fettaminosäuren zur verminderung der absorptionsvariabilität bei zusammensetzungen auf cannabinoid-basis
ES2850277B2 (es) * 2019-01-10 2025-10-15 Innovacorium Inc Composiciones de administración farmacéutica y usos de las mismas
IL302462A (en) * 2020-10-28 2023-06-01 Izun Pharmaceuticals Corp Treatment of oral mucositis
FR3124378B1 (fr) * 2021-06-24 2024-10-25 Bobs Silver Composition antiseptique pour administration nasale
US20230405044A1 (en) * 2020-11-04 2023-12-21 Bobs Silver Antiseptic composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146633A (en) * 1973-05-07 2000-11-14 The Ohio State University Method for treatment of antigenically modified polypeptides
JPS61165334A (ja) 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
US5162037A (en) * 1988-04-01 1992-11-10 Whitson Laboratories, Inc. Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
AU6208494A (en) 1993-03-02 1994-09-26 Universidad De Valladolid Non-toxic ribosome inactivating proteins (rips) with two chains, process for the preparation thereof and applications
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5977176A (en) * 1995-06-27 1999-11-02 Wise; Ronald D. Compositions for the treatment of warts and herpes
US6428819B1 (en) * 1996-12-15 2002-08-06 David Lavie Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
US6039949A (en) * 1997-02-27 2000-03-21 Campamed, Inc. Method of preparation and composition of a water soluble extract of the plant species uncaria
KR100228873B1 (ko) 1997-03-24 1999-11-01 강재헌 센텔라아시아티카에서 분리한 아시아티코사이드와 마테카소 사이드의 수용성 추출물을 함유한 간세포 및 항간섬유화 치료제
JPH10279468A (ja) 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The 皮膚外用剤
US5834000A (en) * 1997-04-11 1998-11-10 Yng-Wong; Quing Non Antiviral and antimicrobial herbal complex
FR2770776B1 (fr) 1997-11-07 2000-03-17 Lvmh Rech Utilisations du d-xylose et de ses esters pour ameliorer la fonctionnalite des cellules de l'epiderme
KR20060123663A (ko) 1999-08-27 2006-12-01 미시간 스테이트 유니버시티 천연 사이클로옥시게나제 저해물질을 함유하는 조성물
JP2001098263A (ja) 1999-09-30 2001-04-10 Fancl Corp 新規抗酸化組成物及び抗炎症組成物
EP1236466B1 (de) * 2001-02-28 2011-09-21 Axiomedic Ltd. Feste selbst-haftende Zusammensetzungen zur topischen Behandlung von Störungen der Mundschleimhaut
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US7565466B2 (en) * 2006-03-22 2009-07-21 Infineon Technologies Ag Memory including an output pointer circuit

Also Published As

Publication number Publication date
JP2004530698A (ja) 2004-10-07
CA2447180A1 (en) 2002-11-28
EP1395271A1 (de) 2004-03-10
US9855307B2 (en) 2018-01-02
US7563466B2 (en) 2009-07-21
US20090186104A1 (en) 2009-07-23
CA2447180C (en) 2014-07-08
IL143318A0 (en) 2002-04-21
US20090297641A1 (en) 2009-12-03
EP1395271B1 (de) 2008-12-17
JP4465155B2 (ja) 2010-05-19
ES2319968T3 (es) 2009-05-18
PT1395271E (pt) 2009-03-23
US20040151789A1 (en) 2004-08-05
DE60230407D1 (de) 2009-01-29
US8075926B2 (en) 2011-12-13
US20140193345A1 (en) 2014-07-10
US20110052733A1 (en) 2011-03-03
WO2002094300A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ATE417621T1 (de) Kräuterzusammensetzungen zur behandlung von schleimhautläsionen
Tripathi et al. A review on ethnopharmacological applications, pharmacological activities, and bioactive compounds of Mimosa pudica (linn.)
Nadiroğlu et al. An ethnobotanical survey of medicinal plants in Karlıova (Bingöl-Turkey)
Ugulu et al. The investigation and quantitative ethnobotanical evaluation of medicinal plants used around Izmir province, Turkey
Bonet et al. Studies on pharmaceutical ethnobotany in the regions of L’Alt Empordà and Les Guilleries (Catalonia, Iberian Peninsula)
WO2004082597A3 (en) Homeopathic formulations useful for treating pain and/or inflammmation
Yang et al. Effect of Angelica sinensis on the proliferation of human bone cells
ATE475716T1 (de) Zusammenstellungen zur behandlung von neurodegenerativen erkrankungen
DE60136348D1 (de) Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
ATE407690T1 (de) Topische pharmazeutische zusammensetzungen enthaltend aktive natürliche bestandteile zur verhütung und behandlung von mucosalen entzündungprozessen
Cavero et al. Pharmaceutical ethnobotany in the middle Navarra (Iberian Peninsula)
Benkhnigue et al. Ethnobotanical and ethnopharmacological study of medicinal plants used in treating some liver diseases in the Al-Haouz Rehamna region (Morocco).
DK2211884T3 (da) Hydrolysater fremstillet af planteekstrakter og antibakterielt middel indeholdende det samme
NO20006430D0 (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
Calvo et al. The pharmacological validation of medicinal plants used for digestive problems in Navarra, Spain
BR0313082A (pt) Extratos de echinacea angustifolia
Girija et al. Aristolochia bracteolata enhances wound healing in vitro through anti-inflammatory and proliferative effect on human dermal fibroblasts and keratinocytes.
Kartal et al. Medicinal plants used in meriç town from Turkey
Ansari et al. Hepatocurative effect of Saussurea lappa, CB Clarke and Artemisia absinthium, Linn in chronic hepatitis B
RU96109803A (ru) Лечебно-профилактическое средство "простанорм"
DE59900222D1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
WO2003013564A3 (en) An herbal composition for the treatment and remedy of bronchial respiratory difficulties
Hussain et al. Ethno-medicinal plants of Tahsil Barawal Bandi Dir Upper Khyber Pakhtunkhwa Pakistan
CN109394903B (zh) 一种以龙脑香樟为君的口腔护理组合物
DE60310125D1 (de) Feste mucoadhesive zusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties